Skip to content
Catalyst

Andrographis paniculataFinding

Andrographis paniculata has no detected effect on adverse event occurrence (oral or enteral supplement)

no difference foundVery limited evidenceFinding

01 · The sentence it was drawn from

“In both placebo and KalmCold treated groups, there were only a few minor adverse effects with no significant difference in occurrence (Z = 0.63; p > 0.05).”
Quoted verbatim from A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection.
This finding among the 13 findings on its endpoint

Andrographis paniculata

Adverse event occurrence (oral or enteral supplement)

no difference found

Who
Patients with uncomplicated upper respiratory tract infection, both sexes
Dose studied
200 mg/day

Very limited evidencePMID 20092985 · 2010

02 · The study

Study
RCT
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7FR5Z2MXPR9N5AQCA7AEQS1